Heart failure with preserved ejection fraction (HFpEF) is recognised as an increasingly
prevalent, morbid and burdensome condition with a poor outlook. Recent advances in both …

Heart failure with preserved ejection fraction (HFpEF) does not exist as a singular clinical or
pathological entity but as a syndrome encompassing a wide range of clinical and biological …

Heart failure with preserved ejection fraction (HFpEF) is an increasingly prevalent
phenotype affecting over half of today's heart failure patients. With no proven therapy and no …

Heart failure with preserved ejection fraction (HFpEF) remains a poorly characterized
syndrome with many unknown aspects related to different patient profiles, various …

Understanding of the pathophysiology of heart failure with preserved ejection fraction
(HFpEF) has advanced rapidly over the past two decades. Currently, HFpEF is recognized …

Heart failure with a preserved ejection fraction (HFpEF) is increasingly prevalent and a
leading cause of morbidity and mortality worldwide. HFpEF has a complex pathophysiology …

Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous disorder
developing from multiple aetiologies with overlapping pathophysiological mechanisms …

Heart failure with preserved ejection fraction (HFpEF) is increasingly prevalent and now
accounts for half of all heart failure cases. This rise is largely attributed to growing rates of …

Heart failure with preserved ejection fraction (HFpEF) traditionally has been characterized
as a form of heart failure without therapeutic options, in particular with a lack of response to …

Heart failure with preserved ejection fraction (HFpEF) has been previously defined by
various criteria, 1 with a common theme being the presence of preserved left ventricular …